[email protected]

Advent Life Sciences

Moximed announces Dr Shahzad Malik and Brigitte Smith to its Board along with raising $50m Series C financing

– USA, CA – Moximed®, Inc., developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA), announced today an oversubscribed Series C round of $50MM with new investors Advent Life Sciences and Future Fund joining existing investors NEA, Morgenthaler Ventures, Gilde Healthcare, GBS Venture Partners, and Vertex Healthcare.… => Read more

Arrakis Therapeutics appoints Michael Gilman as Chairman and CEO along with raising $38m Series A financing led by Canaan Partners

– USA, MA – Arrakis Therapeutics, a pioneering biopharmaceutical company, has completed a $38 million Series A financing led by Canaan Partners with participation by Advent Life Sciences, Pfizer Inc., Celgene Corporation, Osage University Partners, and biotech industry leader Henri Termeer.… => Read more

NeRRe Therapeutics strengthens its Board along with raising £23m Series B financing

– UK, Stevenage – NeRRe Therapeutics, a clinical-stage company developing a unique portfolio of neurokinin receptor antagonists for the treatment of common, chronic and debilitating conditions caused by neuronal hypersensitivity, announced it has raised £23 million in an oversubscribed Series B financing round.… => Read more

Vestagen appoints Bill Bold to its Board as CEO along with raising $7m financing led by Advent Life Sciences and HealthQuest Capital

– USA, FL – Vestagen Technical Textiles, Inc., a medical technology company developing and marketing high performance apparel for healthcare and other demanding applications, today announced it has named Bill Bold Chief Executive Officer.… => Read more

Axonics Modulation Technologies announces Shahzad Malik to its Board after raising $38.5m in Series B financing

– USA, CA – Axonics Modulation Technologies, Inc., developer of miniaturised implantable Sacral Neuromodulation technology, announced today that it has completed a $38.5 million Series B financing.… => Read more